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Abstract: Malignant pigmented villonodular synovitis (PVNS) (or malignant giant cell tumor of tendon sheath (GCTTS) 
is an extremely rare condition defined as a malignant lesion occurring with concomitant or previously documented PVNS 
at the same site. To date, only less than 20 cases have been reported in English literatures. We report a case of malignant 
PVNS in the knee in a 56-year-old woman with unpredictable rapid progression. This case raised a caution that when 
atypical components in specimens of recurrent benign PVNS are detected, even if low-grade or tiny, both pathologists and 
surgeons should consider the risk of malignant PVNS, which could display aggressive clinical progression. 
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CASE PRESENTATION 
  A 56-year-old woman with a painful mass in the 
posterior part of the left knee was admitted to a nearby clinic 
in 1995. Magnetic resonance imaging (MRI) demonstrated a 
lobular mass (Fig. 1a). Subtotal removal was performed in 
June 1996 in that clinic under the diagnosis of conventional 
pigmented villonodular synovitis. Although local recurrence 
was detected 6 months after surgery, no plan was made for 
excision because the disease remained stable during the next 
10 years. She was followed by the clinic. Later, for diagnosis 
confirmation, we accessed the specimen from the first 
operation, revealing marked proliferation of synovia, nodular 
growth, scattered hemosiderin-laden macrophages and 
osteoclastic giant cells. No focal sarcomatous components 
were identified anywhere in the specimen. These findings 
met the diagnostic criteria for benign PVNS (Fig. 1b, c). 
  Due to the progressive intolerable pain lasting for 6 
months in 2006, she visited our institute. Plain radiography 
revealed osteolytic lesions in both the femur and the tibia. 
MRI demonstrated abnormal masses around the knee joint 
with bone invasion (Fig. 2a). A second excision was 
therefore performed in December 2006 under a diagnosis of 
residual PVNS. For extra-articular lesion, marginal resection 
was performed. Curettage and artificial bone graft were 
performed for intraosseous lesion. A large part of the 
specimen from the second operation revealed typical PVNS. 
However, a subtle nodular myxomatous focus with transition 
from ordinary PVNS was apparent (Fig. 2b). Atypical 
spindle cells were seen proliferating in the myxoid stroma 
(Fig. 2c). Solid nodule of pleomorphic and spindle cells in 
other aspects with transition from conventional PVNS area  
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were confirmed (Fig. 2d, e). In these areas, MIB-1 index (the 
percentage of Ki-67-positive cells based on a count of 1000 
tumor cells within the tumor) was, however, less than 15%. 
Pleomorphism was not evident. No necrotic lesion was seen 
throughout the specimen. Thus at that time, it was difficult to 
determine whether this condition was benign or low grade 
malignancy and we decided to perform intensive observation 
at the outpatients’ clinic. 
  During the next 3 months, rapid and aggressive relapse 
progressed with pathological fractures occurring in the distal 
femur and proximal tibia (Fig. 3a). Soft tissue invasion was 
detected up to the proximal part of the thigh (Fig. 3b). 
Therefore we decided to undergo disarticulation for local 
control (Fig. 3c, d). The specimen from the third operation 
showed a destructive multi-nodular growth pattern with 
myxomatous and solid components. The lesion displayed 
atypical spindle cells, similar to those in the tiny atypical 
focus of the second specimen (Fig. 3e). Although a very 
subtle trace of a benign PVNS-like component was detected, 
most of the specimen was occupied by low-grade malignant 
component. High grade component was not detected 
throughout the specimen. Immunohistochemical studies 
including S-100, desmin, smooth muscle actin, and CD99, 
revealed no significant differentiation markers in these 
components from both second and third operations. Again, 
MIB-1 index was less than 15%. 
  Suspected multiple metastases were identified on the first 
lumbar vertebra and pelvis 11 months after the third surgery. 
We prescribed a course of postoperative chemotherapy using 
ifosfamide (10g/m
2) and doxorubicin (60mg/m
2), following 
administration of zoledronate and carbon ion radiotherapy 
for local control of bone metastases. The patient remains 
alive with the disease 21 months after the third operation 
without evident lung metastases. The patient was informed 
that data concerning the case would be submitted for 
publication, and she consented. 
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Fig. (1). First operation at nearby clinic. a; MRI before the first 
excision, showing a well-demarcated lobular mass at the posterior 
part of the knee. b and c; Histological findings of the specimen 
from the first excision, showing conventional PVNS without any 
trace of malignancy (hematoxylin and eosin stain, b; original 
magnification x40, c; x200). 
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Fig. (2). Second operation. a; MRI showing enlargement of the 
residual tumor together with bone destruction. b-e: Specimen from 
the second excision (hematoxylin and eosin stain, b; original 
magnification x20, c; x200, d; x20, e; x200). Malignant PVNS in the Knee  The Open Orthopaedics Journal, 2011, Volume 5    15 
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Fig. (3). Third operation. a and b; MRI at 3 months after the second 
operation. Whole bone occupation is seen, with pathological 
fracture in the femur. Broad subcutaneous occupation is also 
apparent (a). Tumor invasion into the proximal part of the thigh (b). 
c and d; macroscopic findings of the specimen from the 
disarticulated limb. e; Lobular proliferation of atypical tumor cells, 
myxoid stroma and dissepiments throughout the specimen 
(hematoxylin and eosin stain, original magnification x200). No high 
grade component was detected throughout the specimen. 
DISCUSSION 
  Malignant PVNS is an extremely rare condition but 
established concept involving a malignant form of GCTTS 
or PVNS. Enzinger and Weiss proposed the definition of the 
condition as a malignant lesion occurring with concomitant 
or previously documented conventional PVNS at the same 
site [1].
  In the present case, both clinical and histological 
data met this criterion, warranting the diagnosis of malignant 
PVNS. 
  Although some of the previous cases reported as 
malignant PVNS were not accepted as this entity by ohter 
authors [1, 2], to date, about 20 cases of this entity were 
reported in English literatures [2-13]. Clinical property of 
this entity was summarized as follows based on these 
reports. Their ages ranging from 12 to 78, average 52, years. 
Most cases involved the knee and the ankle [2-4, 6, 8, 9]. 16    The Open Orthopaedics Journal, 2011, Volume 5  Imakiire et al. 
Almost half of the patients died during the follow up period 
[3-6, 10]. Limb salvage was difficult due to repeated local 
recurrence or joint involvement, and for most cases 
amputation was indicated [2-6, 8-10].
  However in some 
younger patients’ cases, lethal events could be avoided for 
more than 40 years after the initial treatment in spite of the 
repeated local recurrence [2-4]. 
 Bertoni  et al. analyzed eight typical cases and extracted 
common histological features: 1) a nodular solid infiltrative 
growth pattern; 2) large, plump round or oval cells; 3) cells 
with large nuclei containing prominent nucleoli; 4) necrotic 
areas; and 5) absence of a zonal pattern of maturation [3]. 
Although features 1), 4) and 5) matched the findings in the 
present case, some interesting variations were seen in both 
cell shape and background components, specifically in the 
form of short spindle cells with nodular myxoid infiltrative 
pattern. We propose here that the present case represents an 
example of malignant PVNS with histological features of 
myxofibrosarcoma. Indeed, cases previously reported as 
malignant PVNS have displayed some variations in 
histological findings diverging from the description by 
Bertoni et al. such as proliferation of spindle-shaped cells [2, 
4, 7], myofibroblast-like components [9], osteosarcomatous 
lesion [11] or myxoid components [4, 14]. 
  The notable feature of the present case was the 
discrepancy between low-grade histological findings and 
rapid, extensive clinical progression. Malignant components 
from both the second and third operation showed a low 
mitotic rate. Atypia and pleomorphism were not evident. 
Areas of necrosis were not dominant. All these findings 
suggested low histological grade. We failed to make rational 
explanation for the discrepancy, however, examples of 
aggressive clinical behavior of malignant PVNS with rather 
low mitotic rate (<10 per 10 high-power fields) have been 
previously reported [4, 10]. Our experience suggested a 
strong need for an appropriate and careful pathological work 
up for discriminating between conventional and malignant 
PVSN. In cases of less experienced pathologic centers, a 
transfer to an expert might be kept in mind. 
CONCLUSION 
 An unusual form of malignant PVNS with 
myxofibrosarcoma-like components was reported. This case 
indicated that caution is warranted regarding the probability 
of unpredictable rapid clinical progression in aggressive or 
malignant PVNS, even when histological grade appears low. 
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